# Treatment Of Chronic Anal Fissure

> **NCT02158013** · NA · TERMINATED · sponsor: **Bispebjerg Hospital** · enrollment: 55 (actual)

## Conditions studied

- Chronic Anal Fissure

## Interventions

- **OTHER:** Levorag Emulgel
- **DRUG:** Diltiazem

## Key facts

- **NCT ID:** NCT02158013
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09-01
- **Primary completion:** 2018-02-05
- **Final completion:** 2018-02-05
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Slow inclusion rate
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158013, "Treatment Of Chronic Anal Fissure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02158013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*